|
| Formoterol Impurity 13 Basic information |
Product Name: | Formoterol Impurity 13 | Synonyms: | 2-amino-4-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenol;Formoterol EP Impurity A;Formoterol Impurity A (Mixture of Diastereomers);Formoterol Impurity 1(Formoterol EP Impurity A);Formoterol impurity 1/Formoterol EP Impurity A(Mixture of Diastereomers)/Deformyl Formoterol (Mixture of Diastereomers)/3-Amino-4-hydroxy-α-[[[2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol;Formoterol EP Impurity A
(Mixture of Diastereomers);Formoterol Impurity 1(Mixture of Diastereomers);Benzenemethanol, 3-amino-4-hydroxy-α-[[[2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]- | CAS: | 150513-24-9 | MF: | C18H24N2O3 | MW: | 316.39 | EINECS: | | Product Categories: | | Mol File: | 150513-24-9.mol | |
| Formoterol Impurity 13 Chemical Properties |
Boiling point | 545.7±50.0 °C(Predicted) | density | 1.195±0.06 g/cm3(Predicted) | solubility | DMSO (Slightly), Methanol (Slightly) | pka | 9.81±0.31(Predicted) | form | Solid | color | Pale Yellow to Light Yellow | Stability: | Hygroscopic |
| Formoterol Impurity 13 Usage And Synthesis |
Uses | Deformyl Formoterol Dihydrochloride, can be used in therapeutic use, biological activity and study, and synthetic preparation of desformoterol diastereomers as b2-adrenoceptor agonists. |
| Formoterol Impurity 13 Preparation Products And Raw materials |
|